Genetic variants and normal tissue toxicity after radiotherapy: A systematic review

Radiotherapy and Oncology

Volumn 92, Issue 3, 2009, Pages 299-309

  Andreassen, Christian Nicolaj ^a   Alsner, Jan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Genetic variants; Normal tissue toxicity; Radiotherapy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; RAD50 PROTEIN;

BREAST CANCER; CANCER RADIOTHERAPY; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK CANCER; HETEROZYGOSITY; HUMAN; LUNG NON SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOSENSITIVITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TOXICITY;

CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENETIC VARIATION; HUMANS; MALE; MODELS, GENETIC; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RADIATION GENETICS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; REFERENCE VALUES; RISK ASSESSMENT;

EID: 69949163710     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.06.015     Document Type: Review

References (81)

1. Bentzen S.M., and Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol 4 (1994) 68-80
2. Gotoff S.P., Amirmokri E., and Liebner E.J. Ataxia telangiectasia. Neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am J Dis Child 114 (1967) 617-625
3. Taylor A.M., Harnden D.G., Arlett C.F., et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258 (1975) 427-429
4. Andreassen C.N., Alsner J., and Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it?. Radiother Oncol 64 (2002) 131-140
5. Ahn J., Ambrosone C.B., Kanetsky P.A., et al. Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clin Cancer Res 12 (2006) 7063-7070
6. Ambrosone C.B., Tian C., Ahn J., et al. Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res 8 (2006) R40
7. Andreassen C.N., Alsner J., Overgaard M., and Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69 (2003) 127-135
8. Andreassen C.N., Alsner J., Overgaard J., et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75 (2005) 18-21
9. Andreassen C.N., Alsner J., Overgaard M., Sørensen F.B., and Overgaard J. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM - a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol 82 (2006) 577-586
10. Andreassen C.N., Overgaard J., Alsner J., et al. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 776-783
11. Andreassen C.N., Grau C., Alsner J., and Overgaard J. On behalf of the Danish Head, Neck cancer Study Group. Are TGF-beta 1 polymorphisms potential predictors of fibrosis risk after radiotherapy? - a subset analysis from the DAHANCA 6, 7 protocols. Eur J Cancer Suppl 5 (2007) 119
12. Angele S., Romestaing P., Moullan N., et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63 (2003) 8717-8725
13. Appleby J.M., Barber J.B., Levine E., et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76 (1997) 1546-1549
14. Azria D., Ozsahin M., Kramar A., et al. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 14 (2008) 6284-6288
15. Badie C., Dziwura S., Raffy C., et al. Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br J Cancer 98 (2008) 1845-1851
16. Borgmann K., Roper B., El-Awady R., et al. Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol 64 (2002) 141-152
17. Brem R., Cox D.G., Chapot B., et al. The XRCC1-77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis 27 (2006) 2469-2474
18. Bremer M., Klopper K., Yamini P., dix-Waltes R., Dörk T., and Karstens J.H. Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects. Radiother Oncol 69 (2003) 155-160
19. Burri R.J., Stock R.G., Cesaretti J.A., et al. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res 170 (2008) 49-59
20. Cesaretti J.A., Stock R.G., Lehrer S., et al. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 61 (2005) 196-202
21. Cesaretti J.A., Stock R.G., Atencio D.P., et al. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1410-1416
22. Chang-Claude J., Popanda O., Tan X.L., et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11 (2005) 4802-4809
23. Chang-Claude J., Ambrosone C.B., Lilla C., et al. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer 100 (2009) 1680-1686
24. Clarke R.A., Goozee G.R., Birrell G.W., et al. Absence of ATM truncations in patients with severe acute radiation reactions. Int J Radiat Oncol Biol Phys 41 (1998) 1021-1027
25. Damaraju S., Murray D., Dufour J., et al. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 12 (2006) 2545-2554
26. De Ruyck K., Van Eijkeren M., Claes K., et al. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys 62 (2005) 1140-1149
27. De Ruyck K., Wilding C.S., Van Eijkeren M., Morthier R., Tawn E.J., and Thierens H. Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence. Radiat Res 164 (2005) 237-244
28. De Ruyck K., Van Eijkeren M., Claes K., et al. TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors. Int J Radiat Oncol Biol Phys 65 (2006) 1240-1248
29. Edvardsen H., Kristensen V.N., Grenaker Alnaes G.I., et al. Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1163-1171
30. Edvardsen H., Tefre T., Jansen L., et al. Linkage disequilibrium pattern of the ATM gene in breast cancer patients, controls; association of SNPs, haplotypes to radio-sensitivity, post-lumpectomy local recurrence. Radiat Oncol 2 (2007) 25
31. Gaffney D.K., Brohet R.M., Lewis C.M., et al. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother Oncol 47 (1998) 129-136
32. Giotopoulos G., Symonds R.P., Foweraker K., et al. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 96 (2007) 1001-1007
33. Green H., Ross G., Peacock J., Owen R., Yarnold J., and Houlston R. Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients. Radiother Oncol 63 (2002) 213-216
34. Hall E.J., Schiff P.B., Hanks G.E., et al. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am 4 (1998) 385-389
35. Ho A.Y., Fan G., Atencio D.P., et al. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 677-684
36. Iannuzzi C.M., Atencio D.P., Green S., Stock R.G., and Rosenstein B.S. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 52 (2002) 606-613
37. Isomura M., Oya N., Tachiiri S., et al. IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res 14 (2008) 6683-6689
38. Kornguth D.G., Garden A.S., Zheng Y., Dahlstrom K.R., Wei Q., and Sturgis E.M. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys 62 (2005) 665-671
39. Kuptsova N., Chang-Claude J., Kropp S., et al. Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer 122 (2008) 1333-1339
40. Langsenlehner T., and Langsenlehner U. TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy: in regard to Peters et al. (Int J Radiat Oncol Biol Phys 2008;70:752-759). Int J Radiat Oncol Biol Phys 71 (2008) 960
41. Leong T., Whitty J., Keilar M., et al. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. Int J Radiat Oncol Biol Phys 48 (2000) 959-965
42. Meyer A., Dörk T., Bogdanova N., et al. TGFB1 gene polymorphism Leu10Pro (c.29T>C), prostate cancer incidence and quality of life in patients treated with brachytherapy. World J Urol 27 (2009) 371-377
43. Moore J., Stock R.G., Cesaretti J.A., et al. Single nucleotide polymorphisms as predictors for development of erectile dysfunction in African-American men treated with radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 69 (2007) S7
44. Moullan N., Cox D.G., Angele S., Romestaing P., Gerard J.P., and Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12 (2003) 1168-1174
45. Oppitz U., Bernthaler U., Schindler D., et al. Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects. Int J Radiat Oncol Biol Phys 44 (1999) 981-988
46. Peters C.A., Stock R.G., Cesaretti J.A., et al. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 752-759
47. Pierce L.J., Strawderman M., Narod S.A., et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18 (2000) 3360-3369
48. Popanda O., Tan X.L., Ambrosone C.B., et al. Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev 15 (2006) 1048-1050
49. Popanda O., Marquardt J.U., Chang-Claude J., and Schmezer P. Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat Res 667 (2009) 58-69
50. Price E.A., Bourne S.L., Radbourne R., et al. Rare microsatellite polymorphisms in the DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somat Cell Mol Genet 23 (1997) 237-247
51. Quarmby S., Fakhoury H., Levine E., et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79 (2003) 137-143
52. Ramsay J., Birrell G., and Lavin M. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol 47 (1998) 125-128
53. Rosenstein B.S., Cesaretti J.A., Stock R.G., et al. A validation study to examine the correlation between possession of variants in the ATM gene with the development of erectile dysfunction in prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) S29
54. Severin D.M., Leong T., Cassidy B., et al. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients. Int J Radiat Oncol Biol Phys 50 (2001) 1323-1331
55. Shanley S., McReynolds K., Ardern-Jones A., et al. Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clin Cancer Res 12 (2006) 7025-7032
56. Shayeghi M., Seal S., Regan J., et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78 (1998) 922-927
57. Suga T., Ishikawa A., Kohda M., et al. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 69 (2007) 685-693
58. Suga T., Iwakawa M., Tsuji H., et al. Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 808-813
59. Tan X.L., Popanda O., Ambrosone C.B., et al. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 97 (2006) 255-262
60. Weissberg J.B., Huang D.D., and Swift M. Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes. Int J Radiat Oncol Biol Phys 42 (1998) 1133-1136
61. Werbrouck J., De R.K., Duprez F., et al. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys 73 (2009) 1187-1195
62. Yuan X., Liao Z., Liu Z., et al. Single Nucleotide Polymorphism at rs1982073:T869C of the TGFb1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol (2009) Epub ahead of time
63. Alsner J., Andreassen C.N., and Overgaard J. Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol 18 (2008) 126-135
64. Barnett G.C., West C.M., Dunning A.M., et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9 (2009) 134-142
65. Skol A.D., Scott L.J., Abecasis G.R., and Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38 (2006) 209-213
66. Altshuler D., Daly M.J., and Lander E.S. Genetic mapping in human disease. Science 322 (2008) 881-888
67. Frazer K.A., Murray S.S., Schork N.J., and Topol E.J. Human genetic variation and its contribution to complex traits. Nat Rev Genet 10 (2009) 241-251
68. McCarthy M.I., and Hirschhorn J.N. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 17 (2008) R156-R165
69. Foulkes W.D. Inherited susceptibility to common cancers. N Engl J Med 359 (2008) 2143-2153
70. Cox A., Dunning A.M., Garcia-Closas M., et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39 (2007) 352-358
71. Dunning A.M., Healey C.S., Baynes C., et al. Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18 (2009) 1131-1139
72. Easton D.F., Pooley K.A., Dunning A.M., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 (2007) 1087-1093
73. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
74. Thomas G., Jacobs K.B., Kraft P., et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41 (2009) 579-584
75. Ahmed S., Thomas G., Ghoussaini M., et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41 (2009) 585-590
76. Cookson W., Liang L., Abecasis G., Moffatt M., and Lathrop M. Mapping complex disease traits with global gene expression. Nat Rev Genet 10 (2009) 184-194
77. Smirnov D.A., Morley M., Shin E., Spielman R.S., and Cheung V.G. Genetic analysis of radiation-induced changes in human gene expression. Nature 459 (2009) 587-591
78. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6 (2006) 702-713
79. Kruse J.J., and Stewart F.A. Gene expression arrays as a tool to unravel mechanisms of normal tissue radiation injury and prediction of response. World J Gastroenterol 13 (2007) 2669-2674
80. Alsner J., Rødningen O.K., and Overgaard J. Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis. Radiother Oncol 83 (2007) 261-266
81. Bodmer W., and Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40 (2008) 695-701